| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1600125 | 注射用重组人源化抗PD-1单克隆抗体 | Recombinant humanized anti-PD-1 monoclonal antibody | Lyophilized | Biological Products(1) | New Drug Application | 2017-04-20 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2017-10-26 | view |